IOLCP · Healthcare · Drug Manufacturers - Specialty & Generic
Composite scorecard: 41/100 — Quality 45 · Valuation 1 · Momentum 100
| Share price | ₹155.43 |
| Market cap | ₹5,021 Cr |
| P/E ratio | 36.5 |
| P/B ratio | 2.8 |
| ROCE | 10.5% |
| Dividend yield | 0.58% |
| Book value | ₹61.24 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹2,319 Cr | ₹138 Cr | 12.0% |
| 2025 | ₹2,079 Cr | ₹101 Cr | 10.0% |
| 2024 | ₹2,133 Cr | ₹134 Cr | 11.0% |
| 2023 | ₹2,217 Cr | ₹139 Cr | 10.0% |
| 2022 | ₹2,184 Cr | ₹168 Cr | 12.0% |
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company operates through, Chemical and Pharmaceutical segments. The Chemical segment offers ethyl acetate, iso butyl benzene, acetyl chloride, mono chloro acetic acid, and acetic anhydride to food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries. The Pharmaceutical segment provides active pharmaceutical ingredients, such as ibuprofen, metformin, fenofibrate, lamotrigine, clopidogrel bisulp